Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Knowing what to say when negotiating with creditors is essential for success. Equip yourself with effective phrases and strategies.
12,731 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Some large employers enable a tax-free backdoor into Roth retirement money through a mega backdoor Roth feature. The ...
Investors are tracing a familiar 1990 Gulf War playbook as oil climbs and energy shares outperform, while the broader...
Florida retirees can access beach life without the coastal price tag by choosing inland homes. A growing body of cost...
Applied Optoelectronics and Lumentum jumped about 15% on Monday as a major hyperscale contract and index-driven buyin...
Illinois has floated a plan to fix its long-broken alcohol tax system. This article explains what the proposal actual...
A governance gap in autonomous AI agents threatens personal finances as firms rush AI adoption. Experts warn that unc...
Alphabet signals a strategic pivot as enterprise AI becomes the main growth driver. Google Cloud surges, and a massiv...
Rising prices and medical bills are eroding the buying power of a standard $800k retirement. This report explains how...
Bitcoin and wider crypto markets are eyeing a massive options expiry as traders lean into volatility bets. The option...
Analysts warn that Nvidia's GTC event may not deliver the dramatic stock move some investors were banking on. The con...
As AI accelerates, real-world bottlenecks shape growth and risk for investors. This guide digs into bottlenecks build...